For the first quarter of the fiscal year ending March 2027, net sales were 130,596 million yen, up 10.3% YoY; operating income was 14,264 million yen, up 17.1% YoY; ordinary income was 18,486 million yen, up 63.3% YoY; net income attributable to owners of the parent was 13,333 million yen, up 68.3% YoY. Full-year earnings guidance was revised; pre-goodwill and other amortization operating income is expected to be 85,000 million yen. The overseas mix increased, and segments including measuring instruments, medical devices, industrial devices, and aircraft equipment remained solid. The impact of business combinations, including the acquisition of Tescan Group, is noted.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7701","jir_company_name":"Shimadzu Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/7701-20260806-01.pdf","jir_short_summary":"For the first quarter of the fiscal year ending March 2027, net sales were 130,596 million yen, up 10.3% YoY; operating income was 14,264 million yen, up 17.1% YoY; ordinary income was 18,486 million yen, up 63.3% YoY; net income attributable to owners of the parent was 13,333 million yen, up 68.3% YoY. Full-year earnings guidance was revised; pre-goodwill and other amortization operating income is expected to be 85,000 million yen. The overseas mix increased, and segments including measuring instruments, medical devices, industrial devices, and aircraft equipment remained solid. The impact of business combinations, including the acquisition of Tescan Group, is noted.","jir_summary":"### Overview of results\nShimadzu Corporation achieved significant top- and bottom-line growth in the first quarter of the fiscal year ending March 2027, with net sales of 130,596 million yen (up 10.3% YoY), operating income of 14,264 million yen (up 17.1% YoY), ordinary income of 18,486 million yen (up 63.3% YoY), and net income attributable to owners of the parent of 13,333 million yen (up 68.3% YoY). Segments, including measuring instruments, medical devices, industrial devices, and aircraft equipment, remained solid. The impact of business combinations including the Tescan Group acquisition is noted.\n\n### Outlook and capital plan\nFull-year consolidated earnings guidance has been revised upward; pre-goodwill and other amortization operating income is expected to be 85,000 million yen. While affected by exchange rates, the company will benefit from a weaker yen, capturing growth in semiconductor-related demand globally and the pharmaceutical market, while expanding recurring revenue businesses. An upward revision reflecting the Tescan Group acquisition is implemented.","jir_financial_highlights":"Net sales: 130,596 (YoY +10.3%)\nOperating income: 14,264 (YoY +17.1%)\nOrdinary income: 18,486 (YoY +63.3%)\nNet income attributable to owners of the parent: 13,333 (YoY +68.3%)\nPre-goodwill and other amortization operating income: 14,638 (YoY +16.8%)\nFull-year net sales forecast: 620,000 (Previous forecast 620,000 \u2192 Current forecast 620,000; no change (revised))","jir_category":"","jir_hashtags":"#Shimadzu, #Earnings, #Medium-termManagementPlan, #TescanAcquisition","jir_key_figures":"Net sales: 130,596 million yen\nOperating income: 14,264 million yen\nNet income attributable to owners of the parent: 13,333 million yen","jir_meta_title":"Shimadzu Corporation Q1 FY2027 Earnings Release | Sales Rise, Tescan Acquisition Impact","jir_meta_description":"Key points from Shimadzu Corporation's Q1 FY2027 earnings summary. Net sales rose 10.3% YoY to 130,596 million yen; operating income 14,264 million yen; ordinary income 18,486 million yen; net income 13,333 million yen. Full-year forecast revised; pre-goodwill amortization profit expected at 85,000 million yen. Tescan Group acquisition effects referenced.","jir_og_title":"Shimadzu Q1 Earnings \u2013 Revenue and Profit Up Significantly","jir_og_description":"Shimadzu Corporation's Q1 FY2027 results. Net sales were 130,596 million yen, operating income 14,264 million yen, net income 13,333 million yen. Full-year forecast revised to reflect Tescan acquisition contributions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue (million yen)\\\",\\\"data\\\":[118370,130596,0,0]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (million yen)\\\",\\\"data\\\":[12184,14264,0,0]}]}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026-04\\\",\\\"2026-07\\\",\\\"2026-10\\\",\\\"2027-01\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net income attributable to owners of the parent (million yen)\\\",\\\"data\\\":[7921,13333,0,0]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Measuring Instruments\\\",\\\"Medical Devices\\\",\\\"Industrial Devices\\\",\\\"Aerospace Equipment\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"data\\\":[807? ,169,207,110,16}, {\\\"label\\\":\\\"Previous Quarter\\\",\\\"data\\\":[803,169,207,110,16]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Pre-Goodwill Amortization Operating Margin\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2027Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Pre-Amortization Operating Margin\\\",\\\"data\\\":[10.6,13.0]}]}\"}]","ir_related_company":7490,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-97634","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n